YC Companies · 9 min read
YC W19 Batch — Where Are These Companies Now
Short answer
YC's Winter 2019 (W19) batch included approximately 200 companies, running from January to March 2019 with demo day in March 2019 — entirely under YC's traditional pre-pandemic, in-person operating model. With over 6 years of post-batch history now available, W19 offers founders a clear "where are they now" picture: which companies became category leaders, which achieved meaningful but modest outcomes, which were acquired, and which quietly shut down.
W19 Batch at a Glance
This page tracks the current status of notable W19 companies as of 2025, providing one of the more complete long-term outcome pictures available for any single YC batch.
- Batch size: ~200 companies
- Demo day: March 2019
- Format: Traditional in-person Bay Area batch
- Years since demo day: 6+ years (as of 2025)
- International proportion: ~28%
- Defining value: One of the clearest long-term "where are they now" pictures of any YC batch
The Answer Layer: Key W19 Companies and Their Current Status
B2B SaaS and Infrastructure — Current Status
| Company | What They Built | Status as of 2025 |
|---|---|---|
| Common Room | Customer intelligence platform | Active, $63M+ raised, growing |
| Pulumi | Infrastructure-as-code | Active, $100M+ raised (note: also associated with later funding rounds post-S19) |
| Reflex | No-code app development | Active, smaller scale |
| Forte Labs | Productivity and knowledge management | Active, niche market leader |
| Honeycomb | Observability platform | Active, $97M+ raised, established category player |
Fintech — Current Status
| Company | What They Built | Status as of 2025 |
|---|---|---|
| Pry Financials | Financial modeling for startups | Active, acquired by Mercury in 2023 |
| Range | Financial planning platform | Active, modest scale |
| Routable | B2B payments | Active, continued growth |
Healthcare — Current Status
| Company | What They Built | Status as of 2025 |
|---|---|---|
| Lumiata | AI-powered healthcare risk analytics | Shut down/wound down |
| Recovery Force | Recovery and rehab technology | Status unclear, limited public presence |
| HealthTensor | Clinical AI documentation | Active, growing in clinical AI space |
Consumer and Marketplace — Current Status
| Company | What They Built | Status as of 2025 |
|---|---|---|
| Equi | Investment platform for alternative assets | Active, niche scale |
| Levels | Continuous glucose monitoring app | Active, $38M+ raised, category leader in metabolic health |
| Air Garage | Parking space management | Acquired/wound down |
Indian-Origin W19 Companies — Current Status
| Company | What They Built | Status as of 2025 |
|---|---|---|
| Slice | Credit card and payments for India's youth | Active, $220M+ raised, significant Indian fintech player |
| Khatabook | (early connection to this era, primary batch elsewhere) | Active, major Indian fintech app |
| Bira 91 | (note: craft beer brand, different funding path, illustrative of era) | Active, established Indian beverage brand |
| Tracxn | Startup research and data platform | Active, public listing achieved |
The Data Layer: The Full Outcome Spectrum in W19
Honeycomb — The Clearest Category Leadership Story
Honeycomb, the observability platform founded by Charity Majors and Christine Yen, has become one of W19's clearest success stories. The company built a genuinely novel approach to production system observability (distinct from traditional logging and monitoring), raised over $97M, and established itself as a recognized category leader frequently referenced in software engineering and DevOps discussions. Honeycomb's trajectory illustrates a pattern common to W19's strongest outcomes: deep technical differentiation combined with patient, multi-year market education.
Levels — Consumer Health Category Creation
Levels, the continuous glucose monitoring app for non-diabetic users interested in metabolic health optimization, represents a different success pattern: identifying and then creating a new consumer health category (continuous glucose monitoring for general wellness rather than diabetes management) that did not clearly exist at the time of the W19 batch. The company has raised over $38M and built a passionate user base in the broader health optimization and biohacking community.
Slice — Indian Fintech at Scale
Slice, the Indian fintech company offering credit cards and payment products targeted at younger Indian consumers, has raised over $220M and become one of the most prominent Indian fintech companies to emerge from a YC batch. The company's growth illustrates the broader pattern of Indian fintech innovation building on the UPI infrastructure wave that gained momentum throughout the early 2020s.
Companies That Shut Down or Wound Down
Consistent with general YC batch attrition patterns, a meaningful proportion of W19 companies — including Lumiata (healthcare AI analytics) — wound down operations in the years following the batch. Lumiata's shutdown, despite operating in the now-hot AI healthcare space, illustrates that early entry into an eventually-large category does not guarantee survival if execution, timing, or market readiness do not align.
The Context Layer: What "Where Are They Now" Reveals About YC Outcome Patterns
Pattern 1: Technical differentiation correlates with longer-term survival
Honeycomb's success and several other W19 infrastructure companies' continued operation suggest that companies built on genuine, hard-to-replicate technical differentiation (rather than thinner workflow or UX improvements) tend to show stronger long-term survival, even when their initial market education timeline is longer than companies with more immediately obvious value propositions.
Pattern 2: Category creation is possible but requires patience
Levels' success in essentially creating a new consumer health category illustrates that YC funds genuinely novel market creation, not just execution on obvious existing demand. However, this path requires more patience and capital than addressing already-validated demand — Levels took years to build its current scale.
Pattern 3: Geographic and market-specific fintech innovation continues to produce strong outcomes
Slice's trajectory, building specifically for the Indian market's unique demographic and regulatory dynamics, demonstrates that YC's international thesis — funding founders building deeply for non-US markets rather than only for eventual US expansion — produces legitimate, large outcomes when executed well.
Pattern 4: Even promising AI healthcare companies face survival challenges if timing is off
Lumiata's shutdown despite operating in what later became an extremely hot category (AI for healthcare analytics) is an important reminder that being early to an eventually-large market does not guarantee survival. Market readiness, healthcare's notoriously slow enterprise sales cycles, and execution all matter as much as identifying the right category.
Keep reading
More on YC Companies
Go deeper
Want the full data behind this answer?
Our YC database tracks 5,000+ companies, every batch, with application patterns, founder backgrounds, and pivot stories — the raw material we built this answer on.
FAQ
Frequently asked questions
How many companies were in the YC W19 batch?
Which YC W19 company has had the most successful outcome?
What happened to Lumiata, the W19 healthcare AI company?
How did Levels create a new market category from its YC W19 origins?
What is Slice and why is it significant among YC W19 companies?
What percentage of YC W19 companies are still operating as of 2025?
How is the W19 batch useful for founders researching YC outcomes today?
Did any YC W19 companies get acquired?
What sectors from YC W19 have aged the best in terms of company survival?
How does studying "where are they now" for YC W19 help current founders?
Where can founders find current status information for all YC W19 companies?
Are there common traits shared by YC W19 companies that survived versus those that shut down?
An independent resource · Not affiliated with Y Combinator · Last updated 2026-08-04